PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Clinical Laboratory, The First Affiliated Hospital of Anhui Medical University, Hefei, China.\', \'Key Laboratory of Anti-inflammatory and Immune Medicine, Ministry of Education, Anhui Collaborative Innovation Center of Anti-inflammatory and Immune Medicine, Anhui Anti-inflammatory and Immune Medicine Innovation Team, Institute of Clinical Pharmacology, Anhui Medical University, Hefei, China.\', \'Biohit Healthcare (Hefei) Co., Ltd, Hefei, China.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.3389/fcimb.2020.00470
?:doi
?:hasPublicationType
?:journal
  • Frontiers in cellular and infection microbiology
is ?:pmid of
?:pmid
?:pmid
  • 33014893
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.703
?:rankingScore_hIndex
  • 43
is ?:relation_isRelatedTo_publication of
?:title
  • Serum SARS-COV-2 Nucleocapsid Protein: A Sensitivity and Specificity Early Diagnostic Marker for SARS-COV-2 Infection.
?:type
?:year
  • 2020

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33014893>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33014893>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all